Inspire Medical Systems Stock News

MINNEAPOLIS, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative

MINNEAPOLIS, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative a

Total Clarity Wealth Management Inc. bought a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 120 shares of the companys stock, valued at approximately $28,000. Several other hedge funds and other institutional investors []

Fifth Third Bancorp bought a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) during the 3rd quarter, Holdings Channel.com reports. The firm bought 1,515 shares of the companys stock, valued at approximately $353,000. Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Macquarie Group []

Shares of Inspire Medical Systems, Inc. (NYSE:INSP) have been assigned an average recommendation of Buy from the nine analysts that are presently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price target among []

Equities analysts expect that Inspire Medical Systems, Inc. (NYSE:INSP) will report ($0.48) earnings per share for the current quarter, Zacks reports. Five analysts have made estimates for Inspire Medical Systems earnings. The highest EPS estimate is ($0.43) and the lowest is ($0.56). Inspire Medical Systems posted earnings per share of ($0.28) during the same quarter []

Bank of America Corp DE reduced its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 10.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 90,515 shares of the companys stock after selling 10,098 shares during the period. Bank of []

Equities analysts predict that Inspire Medical Systems, Inc. (NYSE:INSP) will post sales of $65.93 million for the current quarter, according to Zacks. Five analysts have made estimates for Inspire Medical Systems earnings, with the highest sales estimate coming in at $68.20 million and the lowest estimate coming in at $64.93 million. Inspire Medical Systems posted []

Thrivent Financial for Lutherans increased its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 1.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 130,456 shares of the companys stock after purchasing an additional 2,130 shares during the quarter. Thrivent Financial []

Man Group plc decreased its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 42.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,078 shares of the companys stock after selling 14,561 shares during the quarter. Man Group plc []

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q3 2021 Results - Earnings Call Transcript

Inspire (INSP) delivered earnings and revenue surprises of 37.70% and 10.90%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

MINNEAPOLIS, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative a

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.